EP 4133115 A1 20230215 - GENETICALLY REPROGRAMMED MYCOPLASMA BACTERIA AND USES THEREOF
Title (en)
GENETICALLY REPROGRAMMED MYCOPLASMA BACTERIA AND USES THEREOF
Title (de)
GENETISCH NEUPROGRAMMIERTE MYCOPLASMABAKTERIEN UND VERWENDUNGEN DAVON
Title (fr)
BACTÉRIES MYCOPLASMA GÉNÉTIQUEMENT REPROGRAMMÉES ET LEURS UTILISATIONS
Publication
Application
Priority
- EP 20382288 A 20200408
- EP 2021059142 W 20210408
Abstract (en)
[origin: WO2021204928A1] The present invention concerns oligonucleotide arrangements that express gene products having an anti- biofilm activity, and bacteria comprising said oligonucleotide arrangements. Also intended is the use of such arrangements and bacteria as a medicament. Further intended are pharmaceutical compositions comprising genetically modified (e.g. attenuated) Mycoplasma bacteria.
IPC 8 full level
C12R 1/35 (2006.01); A61K 35/00 (2006.01); C12N 15/09 (2006.01)
CPC (source: EP)
A61K 35/74 (2013.01); C12N 1/205 (2021.05); C12N 9/24 (2013.01); C12Y 302/01052 (2013.01); A61K 38/00 (2013.01); C12R 2001/35 (2021.05)
Citation (search report)
See references of WO 2021204928A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
Designated extension state (EPC)
BA ME
Designated validation state (EPC)
KH MA MD TN
DOCDB simple family (publication)
DOCDB simple family (application)
EP 2021059142 W 20210408; EP 21718089 A 20210408